Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20019668 | 0.93 | HTT (0.50) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL22735055 | 0.89 | ALDH1A1 (0.38) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL20019752 | 0.89 | TSHR (0.37) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL17923615 | 0.89 | TSHR (0.37) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL2297941 | 0.89 | ALDH1A1 (0.52) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL308783 | 0.89 | POLB (0.45) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL27098532 | 0.88 | TSHR (0.36) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL28384378 | 0.86 | POLB (0.38) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL22735028 | 0.83 | POLB (0.39) | TSHRPOLBGAAALDH1A1MEN1 | |
| SCHEMBL308635 | 0.83 | LMNA (0.43) | TSHRPOLBGAAALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250357553-A1 | LITHIUM ION SECONDARY BATTERY AND MANUFACTURING METHOD THEREOF | LG ENERGY SOLUTION LTD (KR) | 2025-11-20 | — | — | US | claimed |
| US-12431482-B2 | Silicon oxide based high capacity anode materials for lithium ion batteries | IONBLOX, INC. (US) | 2025-09-30 | — | — | US | claimed |
| EP-4264709-B1 | ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES | SYENSQO SA (BE) | 2025-03-19 | — | — | EP | claimed |
| EP-4510291-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR | LG Energy Solution, Ltd. (KR) | 2025-02-19 | — | — | EP | claimed |
| US-12148889-B2 | Non-aqueous electrolyteincluding lithium bis(fluorosulfonyl)imide, fluorinated acyclic carboxylic acid ester, organic carbonate and electrolyte salt | SYENSQO SA (BE) | 2024-11-19 | — | — | US | claimed |
| EP-3738167-B1 | NON-AQUEOUS ELECTROLYTE COMPOSITIONS COMPRISING LITHIUM BIS(FLUOROSULFONYL)IMIDE | SYENSQO SA (BE) | 2024-04-10 | — | — | EP | claimed |
| US-20240106000-A1 | ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES | SOLVAY SA (BE) | 2024-03-28 | — | — | US | claimed |
| WO-2023239074-A1 | LITHIUM SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR | 주식회사 엘지에너지솔루션 | 2023-12-14 | — | — | WO | claimed |
| EP-4264709-A1 | ELECTROLYTE COMPOSITION FOR LITHIUM METAL BATTERIES | Solvay SA (BE) | 2023-10-25 | — | — | EP | claimed |
| CN-113429259-B | Fluorine-containing compound and application thereof | 中国科学院上海有机化学研究所 | 2023-03-24 | — | — | CN | claimed |
| US-8735621-B2 | Preparation of carbamates with solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-05-27 | — | — | US | claimed |
| WO-2014015335-A1 | ANODE MATERIALS FOR LI-ION BATTERIES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-01-23 | — | — | WO | claimed |
| US-20120295155-A1 | SILICON OXIDE BASED HIGH CAPACITY ANODE MATERIALS FOR LITHIUM ION BATTERIES | IONBLOX, INC. | 2012-11-22 | — | — | US | claimed |
| WO-2012158608-A1 | SILICON OXIDE BASED HIGH CAPACITY ANODE MATERIALS FOR LITHIUM ION BATTERIES | ENVIA SYSTEMS, INC. (US) | 2012-11-22 | — | — | WO | claimed |
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | UNIVERSIDAD POLITECNICA DE VALENCIA (ES) | 2012-03-01 | — | — | US | claimed |
| EP-2407449-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2012-01-18 | — | — | EP | claimed |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Cientificas C/Serrano, 117 (ES) | 2011-05-26 | — | — | US | claimed |
| EP-2316822-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Científicas (ES) | 2011-05-04 | — | — | EP | claimed |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | REPSOL YPF, S.A. (ES) | 2009-03-26 | — | — | US | claimed |
| EP-2036884-A1 | Process for producing fluorinated isocyanates and carbamates | REPSOL YPF S.A. (ES) | 2009-03-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | CA7, CA2, CA4 | TSHR 3643/4885POLB 1962/4885GAA 2315/4885 |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | ODC1, RCC1, OTC | TSHR 4777/4885POLB 1407/4885GAA 1147/4885 |
| US-20090082588-A1 | Process for producing fluorinated carbamates and isocyanates | SRM, CA4, PRMT3 | TSHR 2447/4885POLB 2622/4885GAA 2784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.